Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: Correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2

Urology

Volumn 65, Issue 5, 2005, Pages 1029-1034

  Ohba, Kojiro ^b   Miyata, Yasuyoshi ^a   Koga, Shigehiko ^b   Kanda, Shigeru ^b   Kanetake, Hiroshi ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; GENE PRODUCT; NUCLEOSIDE DIPHOSPHATE KINASE A; SIALYL LEWIS X ANTIGEN; THYROID HORMONE RECEPTOR BETA;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA CELL; TUMOR VOLUME;

AGED; ANTIGENS, CD15; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION; HUMANS; KIDNEY NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEOSIDE-DIPHOSPHATE KINASE; OLIGOSACCHARIDES; RECEPTOR, ERBB-2; SARCOMA;

EID: 18844374448     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.12.032     Document Type: Article

References (30)

1. M. de Peralta-Venturina, H. Moch, M. Amin Sarcomatoid differentiation in renal cell carcinoma a study of 101 cases Am J Surg Pathol 25 2001 275 284
2. B.M. Mian, N. Bhadkamkar, J.W. Slaton Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma J Urol 167 2002 65 70
3. P. Dal Cin, R. Sciot, H. Van Poppel Chromosomal changes in sarcomatoid renal carcinomas are different from those in renal cell carcinoma Cancer Genet Cytogenet 134 2002 38 40
4. F. Jiang, H. Moch, J. Richter Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal cell carcinomas with sarcomatoid transformation J Pathol 185 1998 382 388
5. P.S. Steeg, G. Bevilacqua, L. Kooper Evidence for a novel gene associated with low tumor metastatic potential J Natl Cancer Inst 80 1988 200 204
6. D. Bevilaqua, M.E. Sobel, L.A. Liotta Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential Cancer Res 49 1989 5185 5190
7. C. Zafon, G. Obiols, J. Castellví nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma J Clin Endocrinol Metab 86 2001 3975 3980
8. W. Müller, A. Schneiders, G. Hommel Expression of nm23 in gastric carcinoma association with tumor progression and poor prognosis Cancer 83 1998 2481 2487
9. Y. Nakagawa, K. Tsumatani, N. Kurumatani Prognostic value of nm23 protein expression in renal cell carcinomas Oncology 55 1998 370 376
10. H. Kanayama, H. Takigawa, S. Kagawa Analysis of nm23 gene expression in human bladder and renal carcinomas Int J Urol 1 1994 324 331
11. A. Ayhan, A. Usubutun, H. Ozen nm23 protein expression in renal cell tumors the role of the cell type Oncol Rep 5 1998 979 983
12. J.Y. Kuo, K.M. Chang, K.K. Chen Immunoreactivity of nm23-H1 protein in renal cell carcinoma Anticancer Res 18 1998 531 536
13. B. Ljungberg, B. Österdahl, C. Mehle Clinical significance of nm23 expression in renal cell carcinoma Urol Res 27 1999 103 107
14. B. Theisinger, M. Engle, M. Seifert NM23-H1 and NM23-H2 gene expression in human renal tumors Anticancer Res 18 1998 1185 1189
15. H. Zhao, M. Jhanwar-Uniyal, P.K. Datta Expression profile of gene associated antimetastatic gene nm23-mediated metastasis inhibition in breast carcinoma cells Int J Cancer 109 2004 65 70
16. F. Liu, Y. Zhang, X.-Y. Zhang Transfection of the nm23-H1 gene into human hepatocarcinoma cell lines inhibits the expression of sialyl Lewis X, α1,3 fucosyltransferase VII, and metastatic potential J Cancer Res Clin Oncol 128 2002 189 196
17. F. Liu, H.-L. Qi, H.-L. Chen Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells J Cancer Res Clin Oncol 126 2000 85 90
18. S. Cheng, M.A. Alfonso-Jaume, P.R. Mertens Tumor metastasis suppressor, nm23-β, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1) Biochem J 366 2002 807 816
19. W.M. Liao, K.Y. Chiu, F.B. Li Expression of nm23 protein in human osteosarcoma in relationship with early metastasis Orthopedics 23 2000 1175 1178
20. Y. Oda, T. Naka, M. Takeshita Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma a clinicopathologic and immunohistochemical study Hum Pathol 31 2000 709 716
21. X expression in advanced gastric carcinoma Br J Cancer 83 2000 1681 1687
22. X antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients Int J Cancer 88 2000 281 286
23. D.J. Slamon, G.M. Clark, S.G. Wong Human breast cancer correlation of relapse and survival with amplification of the HER/neu oncogene Science 235 1987 177 182
24. S. Krüger, G. Weitsch, H. Büttner Her2 overexpression in muscle-invasive urothelial carcinoma of the bladder prognostic implications Int J Cancer 102 2002 514 518
25. H. Koga, S. Naito, M. Nakashima A flow cytometric analysis of the expression of adhesion molecules on human renal cell carcinoma cells with different metastatic potentials Eur Urol 31 1997 86 91
26. M. Rotter, T. Block, R. Bush Expression of HER/neu in renal cell carcinoma correlation with histologic subtypes and differentiation Int J Cancer 52 1992 213 217
27. U. Weidner, S. Peter, T. Strohmeyer Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma Cancer Res 50 1990 4504 4509
28. Z. Latif, A.D. Watters, J.M.S. Bartlett Gene amplification and overexpression of HER2 in renal cell carcinoma BJU Int 89 2002 5 9
29. R.S. Herbst, S. Yano, H. Kuniyasu Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma Clin Cancer Res 6 2000 790 797
30. A. Talvensaari-Mattila, P. Paakko, M. Hoyhtya Matrix metalloproteinase-2 immunoreactive protein a marker of aggressiveness in breast carcinoma Cancer 83 1998 1153 1162